303 related articles for article (PubMed ID: 21158658)
1. Safety and effectiveness of a 2009 H1N1 vaccine in Beijing.
Wu J; Xu F; Lu L; Lu M; Miao L; Gao T; Ji W; Suo L; Liu D; Ma R; Yu R; Zhangzhu J; Liu W; Zeng Y; Li X; Zhang X; Pang X; Deng Y
N Engl J Med; 2010 Dec; 363(25):2416-23. PubMed ID: 21158658
[TBL] [Abstract][Full Text] [Related]
2. Preliminary results: surveillance for Guillain-Barré syndrome after receipt of influenza A (H1N1) 2009 monovalent vaccine - United States, 2009-2010.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2010 Jun; 59(21):657-61. PubMed ID: 20520590
[TBL] [Abstract][Full Text] [Related]
3. Association between Guillain-Barré syndrome and influenza A (H1N1) 2009 monovalent inactivated vaccines in the USA: a meta-analysis.
Salmon DA; Proschan M; Forshee R; Gargiullo P; Bleser W; Burwen DR; Cunningham F; Garman P; Greene SK; Lee GM; Vellozzi C; Yih WK; Gellin B; Lurie N;
Lancet; 2013 Apr; 381(9876):1461-8. PubMed ID: 23498095
[TBL] [Abstract][Full Text] [Related]
4. Acceptance of a vaccine against pandemic influenza A (H1N1) virus amongst healthcare workers in Beijing, China.
Seale H; Kaur R; Wang Q; Yang P; Zhang Y; Wang X; Li X; Zhang H; Zhang Z; MacIntyre CR
Vaccine; 2011 Feb; 29(8):1605-10. PubMed ID: 21211593
[TBL] [Abstract][Full Text] [Related]
5. The risk of Guillain-Barré syndrome associated with influenza A (H1N1) 2009 monovalent vaccine and 2009-2010 seasonal influenza vaccines: results from self-controlled analyses.
Tokars JI; Lewis P; DeStefano F; Wise M; Viray M; Morgan O; Gargiullo P; Vellozzi C
Pharmacoepidemiol Drug Saf; 2012 May; 21(5):546-52. PubMed ID: 22407672
[TBL] [Abstract][Full Text] [Related]
6. Safety of influenza A (H1N1) 2009 monovalent vaccines - United States, October 1-November 24, 2009.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2009 Dec; 58(48):1351-6. PubMed ID: 20010511
[TBL] [Abstract][Full Text] [Related]
7. Surveillance for adverse events following receipt of pandemic 2009 H1N1 vaccine in the Post-Licensure Rapid Immunization Safety Monitoring (PRISM) System, 2009-2010.
Yih WK; Lee GM; Lieu TA; Ball R; Kulldorff M; Rett M; Wahl PM; McMahill-Walraven CN; Platt R; Salmon DA
Am J Epidemiol; 2012 Jun; 175(11):1120-8. PubMed ID: 22582207
[TBL] [Abstract][Full Text] [Related]
8. [Safety and epidemiological effects of the first China-made mass A (H1N1) influenza vaccination].
Ji WY; Lu L; Lü M; Miao L; Gao T; Huang RG; Suo LD; Liu DL; Ma R; Yu R; Zhangzhu JZ; Liu WX; Zeng Y; Li XM; Wu J
Zhonghua Liu Xing Bing Xue Za Zhi; 2010 May; 31(5):481-4. PubMed ID: 21163019
[TBL] [Abstract][Full Text] [Related]
9. Safety of influenza A (H1N1) vaccine in postmarketing surveillance in China.
Liang XF; Li L; Liu DW; Li KL; Wu WD; Zhu BP; Wang HQ; Luo HM; Cao LS; Zheng JS; Yin DP; Cao L; Wu BB; Bao HH; Xu DS; Yang WZ; Wang Y
N Engl J Med; 2011 Feb; 364(7):638-47. PubMed ID: 21288090
[TBL] [Abstract][Full Text] [Related]
10. Effectiveness of seasonal 2008-2009, 2009-2010 and pandemic vaccines, to prevent influenza hospitalizations during the autumn 2009 influenza pandemic wave in Castellón, Spain. A test-negative, hospital-based, case-control study.
Puig-Barberà J; Arnedo-Pena A; Pardo-Serrano F; Tirado-Balaguer MD; Pérez-Vilar S; Silvestre-Silvestre E; Calvo-Mas C; Safont-Adsuara L; Ruiz-García M;
Vaccine; 2010 Nov; 28(47):7460-7. PubMed ID: 20875486
[TBL] [Abstract][Full Text] [Related]
11. Vaccines against influenza A (H1N1) pandemic.
Valdespino-Gomez JL; Garcia-Garcia L; de León-Rosales SP
Arch Med Res; 2009 Nov; 40(8):693-704. PubMed ID: 20304259
[TBL] [Abstract][Full Text] [Related]
12. Immunization-safety monitoring systems for the 2009 H1N1 monovalent influenza vaccination program.
Salmon DA; Akhtar A; Mergler MJ; Vannice KS; Izurieta H; Ball R; Lee GM; Vellozzi C; Garman P; Cunningham F; Gellin B; Koh H; Lurie N;
Pediatrics; 2011 May; 127 Suppl 1():S78-86. PubMed ID: 21502251
[TBL] [Abstract][Full Text] [Related]
13. Pandemic influenza. Europe reconsiders H1N1 flu shots for children.
Enserink M
Science; 2009 Nov; 326(5955):922. PubMed ID: 19965485
[No Abstract] [Full Text] [Related]
14. [Analysis of adverse events following 2009 influenza A (H1N1) vaccinoprophylaxis in Beijing].
Miao L; Lu L; Wu J; Suo LD; Liu DL; Sun MP; Pang XH; Deng Y; Wang XL
Zhonghua Yu Fang Yi Xue Za Zhi; 2010 Oct; 44(10):884-7. PubMed ID: 21176517
[TBL] [Abstract][Full Text] [Related]
15. Design of a robust infrastructure to monitor the safety of the pandemic A(H1N1) 2009 vaccination program in Taiwan.
Huang WT; Chen WW; Yang HW; Chen WC; Chao YN; Huang YW; Chuang JH; Kuo HS
Vaccine; 2010 Oct; 28(44):7161-6. PubMed ID: 20804804
[TBL] [Abstract][Full Text] [Related]
16. Effectiveness of 2008-09 trivalent influenza vaccine against 2009 pandemic influenza A (H1N1) - United States, May-June 2009.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2009 Nov; 58(44):1241-5. PubMed ID: 19910912
[TBL] [Abstract][Full Text] [Related]
17. [Guillain-Barre syndrome and the mass vaccination against A/H1N1. No increase of the risk has been reported so far].
Press R; Andersen O
Lakartidningen; 2010 Mar 10-16; 107(10):666-7. PubMed ID: 20402249
[No Abstract] [Full Text] [Related]
18. Swine flu outbreak. China first to vaccinate against novel H1N1 virus.
Stone R
Science; 2009 Sep; 325(5947):1482-3. PubMed ID: 19762610
[No Abstract] [Full Text] [Related]
19. Guillain-Barre syndrome, influenzalike illnesses, and influenza vaccination during seasons with and without circulating A/H1N1 viruses.
Grimaldi-Bensouda L; Alpérovitch A; Besson G; Vial C; Cuisset JM; Papeix C; Lyon-Caen O; Benichou J; Rossignol M;
Am J Epidemiol; 2011 Aug; 174(3):326-35. PubMed ID: 21652600
[TBL] [Abstract][Full Text] [Related]
20. [Well-functioning strategy for the A/H1N1 pandemic in Varmland. A preliminary summary].
Wik O
Lakartidningen; 2010 Jun 16-29; 107(24-25):1630-3. PubMed ID: 20687426
[No Abstract] [Full Text] [Related]
[Next] [New Search]
